Nano-Encapsulation of Drugs to Target Hepatic Stellate Cells: Toward Precision Treatments of Liver Fibrosis

0
45
Scientists present a brief overview of the role of hepatic stellate cells (HSCs) in the pathogenesis of liver fibrosis, summarize the different types of nanocarriers and their specific delivery applications in liver fibrosis, and highlight the biological barriers associated with the use of nanosystems to target HSCs and approaches available to solve this issue.
[Journal of Controlled Release]
Abstract